Literature DB >> 7819579

Prognostic factors: rationale and methods of analysis and integration.

G M Clark1, S G Hilsenbeck, P M Ravdin, M De Laurentiis, C K Osborne.   

Abstract

With the proliferation of potential prognostic factors for breast cancer, it is becoming increasingly more difficult for physicians and patients to integrate the information provided by these factors into a single accurate prediction of clinical outcome. Here we review Cox's proportional hazards model, recursive partitioning, correspondence analysis, and neural networks for their respective capabilities in analyzing censored survival data in the presence of multiple prognostic factors, and we present some clinical applications where these models have been used.

Entities:  

Mesh:

Year:  1994        PMID: 7819579     DOI: 10.1007/bf00666211

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  Relative risk trees for censored survival data.

Authors:  M LeBlanc; J Crowley
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

2.  A comparison of estimated proportional hazards models and regression trees.

Authors:  M R Segal; D A Bloch
Journal:  Stat Med       Date:  1989-05       Impact factor: 2.373

3.  Survival analysis of censored data: neural network analysis detection of complex interactions between variables.

Authors:  M De Laurentiis; P M Ravdin
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer.

Authors:  G M Clark; C R Wenger; S Beardslee; M A Owens; G Pounds; T Oldaker; P Vendely; M R Pandian; D Harrington; W L McGuire
Journal:  Cancer       Date:  1993-03-15       Impact factor: 6.860

5.  A practical application of neural network analysis for predicting outcome of individual breast cancer patients.

Authors:  P M Ravdin; G M Clark
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

6.  A demonstration that breast cancer recurrence can be predicted by neural network analysis.

Authors:  P M Ravdin; G M Clark; S G Hilsenbeck; M A Owens; P Vendely; M R Pandian; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study.

Authors:  K S Albain; S Green; M LeBlanc; S Rivkin; J O'Sullivan; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  A comparison of all-subset Cox and accelerated failure time models with Cox step-wise regression for node-positive breast cancer.

Authors:  J A Chapman; M E Trudeau; K I Pritchard; C A Sawka; B G Mobbs; W M Hanna; H Kahn; D R McCready; L A Lickley
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  Do we really need prognostic factors for breast cancer?

Authors:  G M Clark
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations.

Authors:  A Thor; C Benz; D Moore; E Goldman; S Edgerton; J Landry; L Schwartz; B Mayall; E Hickey; L A Weber
Journal:  J Natl Cancer Inst       Date:  1991-02-06       Impact factor: 13.506

View more
  9 in total

1.  Artificial intelligence for clinicians.

Authors:  P J Drew; J R Monson
Journal:  J R Soc Med       Date:  1999-03       Impact factor: 5.344

2.  Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model.

Authors:  Klaus Müller; Guido Henke; Sophie Pietschmann; Stefaan van Gool; Steven De Vleeschouwer; André O von Bueren; Inge Compter; Carsten Friedrich; Christiane Matuschek; Gunther Klautke; Rolf-Dieter Kortmann; Thomas Hundsberger; Brigitta G Baumert
Journal:  J Neurooncol       Date:  2015-06-13       Impact factor: 4.130

3.  Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer.

Authors:  Brenda F Kurland; Lanell M Peterson; Jean H Lee; Erin K Schubert; Erin R Currin; Jeanne M Link; Kenneth A Krohn; David A Mankoff; Hannah M Linden
Journal:  Clin Cancer Res       Date:  2016-06-24       Impact factor: 12.531

Review 4.  The Nottingham prognostic index for invasive carcinoma of the breast.

Authors:  Andrew H S Lee; Ian O Ellis
Journal:  Pathol Oncol Res       Date:  2008-06-10       Impact factor: 3.201

5.  A predictive index of axillary nodal involvement in operable breast cancer.

Authors:  M De Laurentiis; C Gallo; S De Placido; F Perrone; G Pettinato; G Petrella; C Carlomagno; L Panico; P Delrio; A R Bianco
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

6.  The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.

Authors:  G M Yousef; A Scorilas; A Magklara; N Memari; R Ponzone; P Sismondi; N Biglia; M Abd Ellatif; E P Diamandis
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

7.  Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.

Authors:  G M Yousef; C A Borgoño; A Scorilas; R Ponzone; N Biglia; L Iskander; M-E Polymeris; R Roagna; P Sismondi; E P Diamandis
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

8.  Artificial neural network analysis in preclinical breast cancer.

Authors:  Gholamreza Motalleb
Journal:  Cell J       Date:  2013-11-20       Impact factor: 2.479

9.  Quantitative electrochemical detection of cathepsin B activity in breast cancer cell lysates using carbon nanofiber nanoelectrode arrays toward identification of cancer formation.

Authors:  Luxi Z Swisher; Allan M Prior; Medha J Gunaratna; Stephanie Shishido; Foram Madiyar; Thu A Nguyen; Duy H Hua; Jun Li
Journal:  Nanomedicine       Date:  2015-05-08       Impact factor: 5.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.